Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Allergien
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Dänemark
  • Deutschland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indonesien
  • Japan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Cough, Cold and Allergy (Hay Fever) Remedies - Colombia

Market Direction
Euromonitor

Euromonitor

9 / 2010
46 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Kolumbien
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


As an immediate effect of the A1 H1 virus, there was a temporary increase in the demand for cold- fighting drugs in order to counteract the problem. However, this was a temporary trend as the Ministry of Social Care (Ministerio de Salud) ran campaigns to inform the public about what the correct measures were to combat the disease. They showed how Rx medications were the ones that needed to be used.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Cough, Cold and Allergy (hay Fever) Remedies in Colombia

Euromonitor International

September 2010

List of Contents and Tables

Executive Summary

Consumer Healthcare Is Affected As GDP Growth Continues To Slow Down

Self-medication Habits Limit the Growth of Consumer Healthcare in Colombia

International Companies Continue To Lead in 2009

Foreign Investment and Local Purchases Strengthen Distribution Channels

Moderate Growth Expected Over the Forecast Period

Key Trends and Developments

Self-medication Remains A Widespread Issue in Colombia

Anti-tobacco Legislation in 2009 Reinforces Law Passed in 2008

Colombian Elders Are Increasingly Targeted by Pharmaceutical Companies

Generics Gain Strength During Economic Downturn

Functional Products Are Expected To Threaten Share of Vitamins and Dietary Supplements

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009

Table 2 Life Expectancy at Birth 2004-2009

Market Data

Table 3 Sales of Consumer Health by Sector: Value 2004-2009

Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009

Table 5 Consumer Health Company Shares by Value 2005-2009

Table 6 Consumer Health Brand Shares by Value 2006-2009

Table 7 Penetration of Private Label by Sector 2004-2009

Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009

Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009

Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014

Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014

Appendix

OTC Registration and Classification

De-listing Or De-reimbursement

Advertising

Packaging and Labelling

Distribution

Vitamins and Dietary Supplements Registration and Classification

Switches

Definitions

Summary 1 Research Sources

Biochem Farmaceútica De Colombia SA

Strategic Direction

Key Facts

Summary 2 Biochem Farmaceútica de Colombia SA: Key Facts

Summary 3 Biochem Farmaceútica de Colombia SA: Operational Indicators

Company Background

Production

Summary 4 Biochem Farmacéutica de Colombia SA: Production Statistics 2009

Competitive Positioning

Summary 5 Biochem Farmaceútica de Colombia SA: Competitive Position 2009

Biogen De Colombia Sa, Laboratorios

Strategic Direction

Key Facts

Summary 6 Biogen de Colombia SA, Laboratorios: Key Facts

Summary 7 Biogen de Colombia SA, Laboratorios: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 8 Biogen de Colombia SA, Laboratorios: Competitive Position 2009

Laboratorios California SA

Strategic Direction

Key Facts

Summary 9 Laboratorios California SA: Key Facts

Summary 10 Laboratorios California SA: Operational Indicators

Company Background

Production

Summary 11 Laboratorios California SA: Production Statistics 2009

Competitive Positioning

Summary 12 Laboratorios California SA: Competitive Position 2009

Laboratorios Genéricos Farmacéuticos SA

Strategic Direction

Key Facts

Summary 13 Laboratorios Genéricos Farmacéuticos SA: Key Facts

Summary 14 Laboratorios Genéricos Farmacéuticos SA: Operational Indicators

Company Background

Competitive Positioning

Summary 15 Laboratorios Genéricos Farmacéuticos SA: Competitive Position 2009

Laboratorios Natural Freshly Infabo Ltda

Strategic Direction

Key Facts

Summary 16 Laboratorios Natural Freshly Infabo Ltda: Key Facts

Summary 17 Laboratorios Natural Freshly Infabo Ltda: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 18 Laboratorios Natural Freshly Infabo LTDA: Competitive Position 2009

Lafrancol SA

Strategic Direction

Key Facts

Summary 19 Lafrancol SA: Key Facts

Summary 20 Lafrancol SA: Operational Indicators

Company Background

Production

Summary 21 Lafrancol SA: Production Statistics 2009

Competitive Positioning

Summary 22 Lafrancol SA: Competitive Position 2009

Omnilife Manufactura De Colombia Ltda

Strategic Direction

Key Facts

Summary 23 Omnilife Manufactura de Colombia Ltda: Key Facts

Summary 24 Omnilife Manufactura de Colombia Ltda: Operational Indicators

Company Background

Production

Summary 25 Omnilife Manufactura de Colombia Ltda: Production Statistics 2009

Competitive Positioning

Summary 26 Omnilife Manufactura de Colombia Ltda: Competitive Position 2009

Tecnoquímicas SA

Strategic Direction

Key Facts

Summary 27 Tecnoquímicas SA: Key Facts

Summary 28 Tecnoquímicas SA: Operational Indicators

Company Background

Production

Summary 29 Tecnoquímicas SA: Production Statistics 2009

Competitive Positioning

Summary 30 Tecnoquímicas SA: Competitive Position 2009

Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009

Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009

Table 14 Sales of Decongestants by Type: Value 2004-2009

Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009

Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009

Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009

Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009

Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009

Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014

Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: